ARNI (Sacubitril/Valsartan)
Treatment for Dilated Cardiomyopathy
Effectiveness
90%
Safety Score
65%
Clinical Trials
1
Participants
25K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
0
ARNI (Sacubitril/Valsartan) Outcomes
for Dilated Cardiomyopathy
Efficacy Outcomes
Overall Effectiveness
+90%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
1 active trial recruiting for ARNI (Sacubitril/Valsartan) in Dilated Cardiomyopathy
Comparative Efficacy of ARNI Versus ACE Inhibitor Therapy in Egyptian Children With Dilated Cardiomyopathy
NCT07197372NOT YET RECRUITING
70 participants
OBSERVATIONAL
Started: May 30, 2026